Makley Amy T, Goodman Michael D, Friend Lou Ann W, Deters Joseph S, Johannigman Jay A, Dorlac Warren C, Lentsch Alex B, Pritts Timothy A
Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA.
J Trauma. 2010 Feb;68(2):305-11. doi: 10.1097/TA.0b013e3181cb4472.
Hemorrhagic shock is the leading cause of potentially preventable death after traumatic injury. Hemorrhage and subsequent resuscitation may result in a dysfunctional systemic inflammatory response and multisystem organ failure, leading to delayed mortality. Clinical evidence supports improved survival and reduced morbidity when fresh blood products are used as resuscitation strategies. We hypothesized that the transfusion of fresh whole blood (FWB) attenuates systemic inflammation and reduces organ injury when compared with conventional crystalloid resuscitation after hemorrhagic shock.
Male mice underwent femoral artery cannulation and hemorrhage to a systolic blood pressure of 25 mm Hg +/- 5 mm Hg. After 60 minutes, the mice were resuscitated with either FWB or lactated Ringer's solution (LR). Mice were decannulated and killed at intervals for tissue histology, serum cytokine analysis, and vascular permeability studies. Separate groups of mice were followed for survival studies.
When compared with FWB, mice resuscitated with LR required increased resuscitation fluid volume to reach goal systolic blood pressure. When compared with sham or FWB-resuscitated mice, LR resuscitation resulted in increased serum cytokine levels of macrophage inflammatory protein-1alpha, interleukin-6, interleukin-10, macrophage-derived chemokine, KC, and granulocyte macrophage colony stimulating factor as well as increased lung injury and pulmonary capillary permeability. No survival differences were seen between animals resuscitated with LR or FWB.
Resuscitation with LR results in increased systemic inflammation, vascular permeability, and lung injury after hemorrhagic shock. Resuscitation with FWB attenuates the inflammation and lung injury seen with crystalloid resuscitation. These findings suggest that resuscitation strategies using fresh blood products potentially reduce systemic inflammation and organ injury after hemorrhagic shock.
失血性休克是创伤性损伤后潜在可预防死亡的主要原因。出血及随后的复苏可能导致全身炎症反应功能失调和多系统器官衰竭,进而导致延迟性死亡。临床证据表明,使用新鲜血液制品作为复苏策略可提高生存率并降低发病率。我们假设,与失血性休克后传统晶体复苏相比,输注新鲜全血(FWB)可减轻全身炎症并减少器官损伤。
雄性小鼠进行股动脉插管并出血,使收缩压降至25 mmHg±5 mmHg。60分钟后,小鼠分别用FWB或乳酸林格氏液(LR)进行复苏。每隔一段时间将小鼠拔管并处死,进行组织组织学检查、血清细胞因子分析和血管通透性研究。另外分组的小鼠进行生存研究。
与FWB相比,用LR复苏的小鼠需要增加复苏液量才能达到目标收缩压。与假手术组或FWB复苏的小鼠相比,LR复苏导致血清中巨噬细胞炎性蛋白-1α、白细胞介素-6、白细胞介素-10、巨噬细胞衍生趋化因子、KC和粒细胞巨噬细胞集落刺激因子的细胞因子水平升高,同时肺损伤和肺毛细血管通透性增加。用LR或FWB复苏的动物之间未观察到生存差异。
失血性休克后用LR复苏会导致全身炎症、血管通透性和肺损伤增加。用FWB复苏可减轻晶体复苏时出现的炎症和肺损伤。这些发现表明,使用新鲜血液制品的复苏策略可能会减少失血性休克后的全身炎症和器官损伤。